These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 38630680)

  • 1. A simulation-based comparison of drug-drug interaction signal detection methods.
    Jung D; Jung I
    PLoS One; 2024; 19(4):e0300268. PubMed ID: 38630680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Signal Detection Algorithms Based on Frequency Statistical Model for Drug-Drug Interaction Using Spontaneous Reporting Systems.
    Noguchi Y; Tachi T; Teramachi H
    Pharm Res; 2020 Apr; 37(5):86. PubMed ID: 32356247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Propensity score-adjusted three-component mixture model for drug-drug interaction data mining in FDA Adverse Event Reporting System.
    Wang X; Li L; Wang L; Feng W; Zhang P
    Stat Med; 2020 Mar; 39(7):996-1010. PubMed ID: 31880829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Bayesian method to detect drug-drug interaction using external information for spontaneous reporting system.
    Tada K; Maruo K; Gosho M
    Stat Med; 2024 Aug; 43(18):3353-3363. PubMed ID: 38840316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identifying adverse drug reactions associated with drug-drug interactions: data mining of a spontaneous reporting database in Italy.
    Leone R; Magro L; Moretti U; Cutroneo P; Moschini M; Motola D; Tuccori M; Conforti A
    Drug Saf; 2010 Aug; 33(8):667-75. PubMed ID: 20635825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Criteria revision and performance comparison of three methods of signal detection applied to the spontaneous reporting database of a pharmaceutical manufacturer.
    Matsushita Y; Kuroda Y; Niwa S; Sonehara S; Hamada C; Yoshimura I
    Drug Saf; 2007; 30(8):715-26. PubMed ID: 17696584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utilization of chi-square statistics for screening adverse drug-drug interactions in spontaneous reporting systems.
    Gosho M; Maruo K; Tada K; Hirakawa A
    Eur J Clin Pharmacol; 2017 Jun; 73(6):779-786. PubMed ID: 28280890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Data-mining for detecting signals of adverse drug reactions of fluoxetine using the Korea Adverse Event Reporting System (KAERS) database.
    Kim S; Park K; Kim MS; Yang BR; Choi HJ; Park BJ
    Psychiatry Res; 2017 Oct; 256():237-242. PubMed ID: 28646789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detecting signals of drug-drug interactions in a spontaneous reports database.
    Thakrar BT; Grundschober SB; Doessegger L
    Br J Clin Pharmacol; 2007 Oct; 64(4):489-95. PubMed ID: 17506784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Data-driven prediction of adverse drug reactions induced by drug-drug interactions.
    Liu R; AbdulHameed MDM; Kumar K; Yu X; Wallqvist A; Reifman J
    BMC Pharmacol Toxicol; 2017 Jun; 18(1):44. PubMed ID: 28595649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A computerized system for detecting signals due to drug-drug interactions in spontaneous reporting systems.
    Qian Y; Ye X; Du W; Ren J; Sun Y; Wang H; Luo B; Gao Q; Wu M; He J
    Br J Clin Pharmacol; 2010 Jan; 69(1):67-73. PubMed ID: 20078614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statistical methods for exploring spontaneous adverse event reporting databases for drug-host factor interactions.
    Lu Z; Suzuki A; Wang D
    BMC Med Res Methodol; 2023 Mar; 23(1):71. PubMed ID: 36973693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovering clinical drug-drug interactions with known pharmacokinetics mechanisms using spontaneous reporting systems and electronic health records.
    Jeong E; Su Y; Li L; Chen Y
    J Biomed Inform; 2024 May; 153():104639. PubMed ID: 38583580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mixture drug-count response model for the high-dimensional drug combinatory effect on myopathy.
    Wang X; Zhang P; Chiang CW; Wu H; Shen L; Ning X; Zeng D; Wang L; Quinney SK; Feng W; Li L
    Stat Med; 2018 Feb; 37(4):673-686. PubMed ID: 29171062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Signal detection of human papillomavirus vaccines using the Korea Adverse Events Reporting System database, between 2005 and 2016.
    Ran J; Yang JY; Lee JH; Kim HJ; Choi JY; Shin JY
    Int J Clin Pharm; 2019 Oct; 41(5):1365-1372. PubMed ID: 31313003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detecting early safety signals of infliximab using machine learning algorithms in the Korea adverse event reporting system.
    Lee JE; Kim JH; Bae JH; Song I; Shin JY
    Sci Rep; 2022 Sep; 12(1):14869. PubMed ID: 36050484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Signal Detection of Imipenem Compared to Other Drugs from Korea Adverse Event Reporting System Database.
    Park K; Soukavong M; Kim J; Kwon KE; Jin XM; Lee J; Yang BR; Park BJ
    Yonsei Med J; 2017 May; 58(3):564-569. PubMed ID: 28332362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early detection of pharmacovigilance signals with automated methods based on false discovery rates: a comparative study.
    Ahmed I; Thiessard F; Miremont-Salamé G; Haramburu F; Kreft-Jais C; Bégaud B; Tubert-Bitter P
    Drug Saf; 2012 Jun; 35(6):495-506. PubMed ID: 22612853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Real-world data-based adverse drug reactions detection from the Korea Adverse Event Reporting System databases with electronic health records-based detection algorithm.
    Shin H; Cha J; Lee Y; Kim JY; Lee S
    Health Informatics J; 2021; 27(3):14604582211033014. PubMed ID: 34289723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Data mining in pharmacovigilance--detecting the unexpected: the role of index of suspicion of the reporter.
    Sundström A; Hallberg P
    Drug Saf; 2009; 32(5):419-27. PubMed ID: 19419236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.